Invisible Shield QuickFire Challenge
Respiratory pathogens are everywhere. While they cannot be seen, they can massively impact individuals and communities. How can we better protect ourselves against these invisible threats? The solution may be an “invisible shield.” The future of pathogen protection can go beyond traditional respiratory devices, to integrate seamlessly into our daily lives, becoming an “invisible shield” against disease.
As a follow-up to the Reimagining Respiratory Protection QuickFire Challenge, the Biomedical Advanced Research and Development Authority (BARDA), a component of the Office of the Assistant Secretary for Preparedness and Response in the U.S. Department of Health and Human Services and Johnson & Johnson Innovation – JLABS, working with Janssen Research & Development, LLC, are proud to introduce the Invisible Shield QuickFire Challenge. Innovators are invited to submit ideas for potential solutions that repel and protect against airborne viruses while integrating seamlessly into everyday life.
The innovator(s) with the best idea will be awarded up to $200,000 in funding from BARDA, access to the Johnson & Johnson Innovation – JLABS ecosystem, and support in developing their ideas from BARDA for one year, to support health security products and technologies in biotechnology, life science research, and medical innovations as they navigate research, development, and regulatory pathways.
- Up to two innovators will be awarded up to $200,000 in funding from BARDA
- Mentorship from BARDA and experts within the Johnson & Johnson Family of Companies for one year
- Access to the Johnson & Johnson Innovation - JLABS ecosystem
What we’re looking for
This Challenge seeks potential solutions that have an intended use to provide protection for individuals and communities from respiratory pathogens, including airborne viruses. Proposed technologies that solely provide protection against industrial or environmental factors, particularly air pollution, will not be considered in this Challenge.
Proposals containing or describing a path forward to meet any of the following criteria are preferred but not required. Please keep in mind that no idea is too big or too early for consideration. Applications that clearly describe a concept or path forward to achieve these goals will also be considered during evaluation. The ideal potential solution would have the following characteristics:
- Suitable for all populations and ages
- Effective in preventing infection
- Easily integrates into daily life
- Simple, requires no special instructions
- Safe, non-toxic to humans and animal life
- Inexpensive or low cost per use